Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-918-1 | CAS number: 111-88-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key data were identified to evaluate the acute oral, dermal, and inhalation toxicity potential of octane-1-thiol. The key parameters are discussed below :
• Acute oral LD50: >2000 mg/kg bw
• Acute dermal LD50: >2000 mg/kg bw
• Acute inhalation LC50: >3.1 mg/L
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Dose descriptor:
- LC50
- Value:
- 3.1 mg/m³ air
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
Acute Oral Toxicity
One key acute study was identified to evaluate the acute oral toxicity potential of octane-1-thiol.
In a key acute oral toxicity study (Moon, 1981a; Klimisch score = 1), groups of fasted, albino rats (5/sex/dose) were given a single oral dose of octane-1-thiol at doses of 1680, 2100, 2688, or 3360 mg/kg bw and subsequently observed for 14 days. Mortality was observed in one animal in the 1680 mg/kg bw dose group while 3, 6, and 9 animals dies in 2100, 2688, and 3360 mg/kg bw dose groups, respectively. Treatment related clinical signs such as lacrimation, loss of activity, ruffed fur, ocular bleeding, and respiratory conditions were seen in animals that died through the study period. Gross necroscopy revealed abnormalities in the lung, liver, stomach, intestines, kidneys, gonads, and ovaries in 3 of 10 animals that were tested at the 1680 mg/kg dose level. 8 of 10 rats dosed at 2100 mg/kg bw were seen to have abnormalities in the lungs, liver, adrenal glands, stomach, spleen, kidneys, and intestines. Abnormalities in multiple organs were seen in all animals that were treated with octane-1-thiol at 2688 and 3360 mg/kg bw. Using probit analysis the oral LD50 for octane-1-thiol was determined to be 2436 mg/kg bw in males and female rats.
In a supporting guideline (OECD 401) acute oral toxicity study (MHLW, 2004; Klimisch score = 1), groups of fasted Sprague-Dawley rats (Crj:CD(SD)IGS,SPF; 5/sex) were given a single oral dose of octane-1-thiol (CAS # 111-88-6) at doses of 0, 250, 500, 1000, 2000 mg/kg bw. The animals were subsequently observed and weighed daily for a period of 14 days. Two male and all female rats in the 2000 mg/kg bw dose group died on day 3 post-exposure. One female rat dosed at 1000 kg/mg bw also died by day 3 post-exposure. Treatment-related clinical signs of toxicity supported by observations at gross necroscopy were observed in male and female rats treated with octane-1-thiol at doses of 1000 and 2000 mg/kg bw. Gross necroscopy also revealed treatment-related effects in female rats dosed at the 500 mg/kg bw dose level. Body weights were observed to be lower in the three highest dose levels by day 2 post-exposure when compared with the corresponding controls. Based on the effects seen, the oral LD50 was determined to be >2000 mg/kg bw in males and 1293 mg/kg bw (95% confidence limit; 889-1780 mg/kg) in female rats.
Supporting data are available from one study conducted in rats. One acute oral toxicity study (Latven, 1958; Klimisch score = 2) reported an LD50 of 2000 mg/kg bw based on mortality observed in 3 of 6 male WBS/W rats orally administered octane-1-thiol.
Based on the weight of evidence of key and supporting data, the acute oral LD50 for octane-1-thiol was determined to be >2000 mg/kg bw.
Acute Dermal Toxicity
One key study in rabbits was identified to evaluate the acute dermal toxicity potential of octane-1-thiol.
In a key acute dermal toxicity study (Moon, 1981b; Klimisch score = 2), groups of New Zealand albino rabbits (3/sex) were dermally exposed to octane-1-thiol for 24 hours at a dose of 1680 mg/kg bw. Animals were subsequently observed for a period of 14 days. There was no mortality observed in either male or female rabbits through the study period. Erythema was observed in all animals on day 1 and persisted through day 6 of the study period. Induration that appeared on day 5 and persisted through day 14 was observed in five of the 6 animals. No treatment-related adverse effects on body weight were observed through the study period and gross necroscopy did not reveal any remarkable findings. In the absence of adverse systemic toxicity effects, the acute dermal LD50 was determined to be >1680 mg/kg bw.
Supporting data available from a study conducted in rats (Latven, 1977; Klimisch score = 2) indicates that the LD50 for octane-1-thiol is >2000 mg/kg bw in rats.
Based on the key data available, octane-1-thiol has a low order of toxicity via the dermal route with an LD50 >2000 mg/kg bw/day.
Acute Inhalation Toxicity
One key acute study was identified to evaluate the acute inhalation toxicity potential of octane-1-thiol.
In a key acute inhalation toxicity study (Collins, 1987; Klimisch score = 2) young adult Sprague-Dawley rats (5/sex) were exposed via the inhalation route (head only) to 3.10 mg/L octane-1-thiol for 4.5 hours. Animals were subsequently observed for a period of 14 days. No treatment-related macroscopic or microscopic changes were evident through the study period. Clinical signs observed during the study were ataxia, lethargy, salivation, lachrymation, and piloerection on the day of exposure. Piloerection was also noted on the day following exposure. Based on the lack of adverse treatment-related effects, the acute inhalation LC50 was determined to be >3.10 mg/L in male and female rats.
In a supporting acute inhalation toxicity study (Hardy and Jackson, 1987; Klimisch score = 1), groups of young adult Sprague-Dawley rats (5/sex) were exposed via the inhalation route (whole body) to octane-1-thiol at concentrations of 0 or 0.24 mg/L. Animals were subsequently observed for 14 days. No mortality was observed in either male or female rats following exposure to octane-1-thiol. During exposure, clinical signs such as hunched body posture and a slow, shallow respiratory pattern were observed. These were attributed to the irritant nature of the vapour. Apart from hyperactivity immediately following exposure, the rats exposed to octane-1-thiol were normal in appearance and behaviour throughout the observation period. Body weight remained unaffected through the study period and gross necroscopy revealed minimal congestion in the lungs of 2 rats exposed to octane-1-thiol. Based on the lack of significant treatment-related signs of clinical toxicity, the acute inhalation LC50 was determined to be >0.24 mg/L.
Supporting data from another study (Yates, 1981; Klimisch score = 1) in rats exposed (whole-body inhalation) to vapours of octane-1-thiol at a concentration of 3.04 mg/L (508 ppm) did not show any treatment-related effects. The LC50 was therefore determined to be >3.04 mg/L in this study.
Justification for classification or non-classification
Octane-1-thiol does not meet the criteria for classification as an acute oral toxicant under EU Dangerous Substances Directive 67/548/EEC or CLP EU Regulation 1272/2008.
Octane-1-thiol does not meet the criteria for classification as an acute dermal toxicant under EU Dangerous Substances Directive 67/548/EEC or CLP EU Regulation 1272/2008.
Octane-1-thiol does not meet the criteria for classification as an acute inhalation toxicant under EU Dangerous Substances Directive 67/548/EEC or CLP EU Regulation 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.